FibroGen (FGEN) Tops Q4 EPS by 2c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $42.5 million versus the consensus estimate of $49.77 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Taiwan Semiconductor Manufacturing Co. Ltd. (2330:TT) (TSM) PT Raised to NT$3,400 at UBS
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance